NorthLinks Bio

Boston, United States

NorthLinks Bio is a clinical-stage biopharmaceutical company developing HEX17.

$34.0M raised

Jun 2026

Venture - Series Unknown

Biotechnology Genetics

Top Investors

RA Capital Management

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NorthLinks Bio

How much funding has NorthLinks Bio raised?

NorthLinks Bio has raised $34.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2026.

Who are NorthLinks Bio's investors?

NorthLinks Bio's investors include RA Capital Management.

Where is NorthLinks Bio headquartered?

NorthLinks Bio is headquartered in Boston, United States.

What does NorthLinks Bio do?

NorthLinks Bio is a clinical-stage biopharmaceutical company developing HEX17.

What stage is NorthLinks Bio at?

NorthLinks Bio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 23, 2026.

MLA

"NorthLinks Bio — Funding & Investors." VCBacked, June 23, 2026, https://www.vcbacked.co/company/northlinks-bio. Accessed July 2, 2026.

APA

VCBacked. (2026). NorthLinks Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/northlinks-bio

Wikipedia (cite web)

{{cite web |title=NorthLinks Bio — Funding & Investors |url=https://www.vcbacked.co/company/northlinks-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 23, 2026.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K